UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
NOTICE OF EFFECTIVENESS
Effective Date:
November 19, 2021
Form:
S-3
CIK:
0001297184
Company Name:
Amphastar Pharmaceuticals, Inc.
File Number:
333-260916